Académique Documents
Professionnel Documents
Culture Documents
There has been a great deal of controversy about the safety of birth control pills for decades.
Considerations of the recognized health benefits and potential risks of birth control pills should keep
this in mind as research dealing with this matter continues.
. Beaber, PhD, MPH, a staff scientist in the Public Health Sciences Division of Fred Hutchinson
Cancer Research Center in Seattle, Washington, says the results of this research suggest that the
use of contemporary oral contraceptives in the past year has an association with increased breast
cancer risk relative to never or former oral contraceptive use. Furthermore, prior studies have
suggested that the increased risk which is associated with recent oral contraceptive use decreases
after the oral contraceptives are stopped.
In this study recent oral contraceptive use was observed to increase breast cancer risk by 50
percent in comparison with never or former use. The results of this study have suggested that the
recent use of contemporary oral contraceptives is associated with an increased risk of breast cancer.
Other woman using other birth control formulations did not have this increased breast cancer risk.
This study has been published in the journal Cancer Research, a journal of the American Association
for Cancer Research. Low-dose estrogen birth control pills did not increase breast cancer risk.
Elisabeth F. Birth control pills with moderate-dose estrogen increased the risk 1.6-fold. New
research shows that the recent use of some types of birth control pills may increase the risk of
breast cancer reported the American Association for Cancer Research on August 1, 2014. Beaber
says these results need confirmation and should be interpreted with caution. According to this
research women who recently used birth control pills which contain high-dose estrogen and a few
other formulations had an increased risk for breast cancer. Breast cancer risk was increased 2.7-fold
with birth control pills containing high-dose estrogen